Blue dye under the microscope: could a routine cataract tool damage corneal cells?

NCT ID NCT07735000

First seen Jul 29, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This trial tests whether trypan blue, a dye sometimes used to stain the lens capsule during cataract surgery, affects the number of corneal endothelial cells — the inner layer of the cornea that keeps it clear. Sixty adults aged 45 to 75 with age-related cataracts will be randomly assigned to receive either standard cataract surgery or surgery with the dye. The main goal is to compare corneal cell counts after surgery to see if the dye causes extra cell loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
trypan blue dye injected into the eye during cataract surgery
What this could lead to
If the dye is found to be safe for corneal cells, it could confirm its continued use in routine cataract surgery.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply to all patients. The dye could potentially cause more cell loss than standard surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Ophthalmology, Hayatabad Medical Complex, Peshawar, Pakistan

    Peshawar, KPK, 25000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.